![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fabiana Auricchio, Cristina Scavone, Daniela Cimmaruta, Gabriella Di Mauro, Annalisa Capuano, Liberata Sportiello & Concetta Rafaniello. (2017) Drugs approved for the treatment of multiple sclerosis: review of their safety profile. Expert Opinion on Drug Safety 16:12, pages 1359-1371.
Read now
Read now
Articles from other publishers (33)
Lyubomir T. Vezenkov, Daniela S. Tsekova, Ivanka KostadinovaRositsa Mihaylova, Valentin Lozanov, Nikolay G. Vassilev, Nikolai Danchev, Ivanka Tsakovska & Ilza Pajeva. (2023) Synthesis and Biological Study of 4-Aminopyridine-Peptide Derivatives Designed for the Treatment of Neurodegenerative Disorders. Current Alzheimer Research 20:2, pages 120-129.
Crossref
Crossref
Muhammed A Saad, Noha M Eissa, Mohammed A Ahmed, Aliaa N ElMeshad, Götz Laible, Ahmed S Attia, Medhat A Al-Ghobashy, Rania M AbdelsalamSnrSnr & Muhammad Y Al-Shorbagy. (2022) Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice. International Journal of Nanomedicine Volume 17, pages 3967-3987.
Crossref
Crossref
Susanta Pahari, Gurpreet Kaur, Shikha Negi, Mohammad Aqdas, Deepjyoti K. Das, Hilal Bashir, Sanpreet Singh, Mukta Nagare, Junaid Khan & Javed N. Agrewala. (2018) Reinforcing the Functionality of Mononuclear Phagocyte System to Control Tuberculosis. Frontiers in Immunology 9.
Crossref
Crossref
Reema Roshan, Ashwani Choudhary, Aksheev Bhambri, Bhawani Bakshi, Tanay Ghosh & Beena Pillai. (2017) microRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cells. Journal of Neuroinflammation 14:1.
Crossref
Crossref
Luke Galloway, Niki Vakili & Julian Spears. (2016) Spontaneous regression of a parafalcine meningioma in a multiple sclerosis patient being treated with interferon beta-1a. Acta Neurochirurgica 159:3, pages 469-471.
Crossref
Crossref
Loredana La Mantia, Carlo Di Pietrantonj, Marco Rovaris, Giulio Rigon, Serena Frau, Francesco Berardo, Anna Gandini, Anna Longobardi, Bianca Weinstock-Guttman & Alberto Vaona. (2016) Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews 2016:11.
Crossref
Crossref
Florian M. Ottenlinger, Christoph A. Mayer, Nerea Ferreir?s, Yannick Schreiber, Anja Schwiebs, Katrin G. Schmidt, Hanns Ackermann, Josef M. Pfeilschifter & Heinfried H. Radeke. (2016) Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab. Frontiers in Pharmacology 7.
Crossref
Crossref
Maryam Kay, Amin Moradi Hasan-Abad, Zohreh Hojati & Hasan Korbekandi. (2016) Targeted mutations in Val101 and Arg27 interferon beta protein increase its transcriptional and translational activities. Cytokine 78, pages 1-6.
Crossref
Crossref
Mei Lin & Hua-peng Yu. (2015) Dexamethasone decreases IL-29 expression in house dust mite-stimulated human bronchial epithelial cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 35:6, pages 823-827.
Crossref
Crossref
Blythe C. Dillingham, Susan M. Knoblach, Gina M. Many, Brennan T. Harmon, Amanda M. Mullen, Christopher R. Heier, Luca Bello, John M. McCall, Eric P. Hoffman, Edward M. Connor, Kanneboyina Nagaraju, Erica K. M. Reeves & Jesse M. Damsker. (2014) VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis. Cellular and Molecular Neurobiology 35:3, pages 377-387.
Crossref
Crossref
Soraya Maria Menezes, Daniele Decanine, David Brassat, Ricardo Khouri, Saul V Schnitman, Ramon Kruschewsky, Giovanni López, Carolina Alvarez, Michael Talledo, Eduardo Gotuzzo, Anne-Mieke Vandamme, Bernardo Galvão-Castro, Roland Liblau & Johan Van Weyenbergh. (2014) CD80+ and CD86+B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis. Journal of Neuroinflammation 11:1.
Crossref
Crossref
Loredana La Mantia, Carlo Di Pietrantonj, Marco Rovaris, Giulio Rigon, Serena Frau, Francesco Berardo, Anna Gandini, Anna Longobardi, Bianca Weinstock-Guttman & Alberto Vaona. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Frances Rena Bahjat, Raffaella Gesuete & Mary P. Stenzel-Poore. 2014. Immunological Mechanisms and Therapies in Brain Injuries and Stroke. Immunological Mechanisms and Therapies in Brain Injuries and Stroke
97
120
.
Fabienne Rehren, Barbara Ritter, Oliver Dittrich-Breiholz, Andreas Henke, Elena Lam, Semra Kati, Michael Kracht & Albert Heim. (2012) Induction of a broad spectrum of inflammation-related genes by Coxsackievirus B3 requires Interleukin-1 signaling. Medical Microbiology and Immunology 202:1, pages 11-23.
Crossref
Crossref
Amedeo Amedei, Domenico Prisco & Mario D’Elios. (2012) Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies. International Journal of Molecular Sciences 13:12, pages 13438-13460.
Crossref
Crossref
Thor Petersen, Anné Møller-Larsen, Svend Ellermann-Eriksen, Steffen Thiel & Tove Christensen. (2012) Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis. Journal of Neuroimmunology 249:1-2, pages 105-108.
Crossref
Crossref
Edward FoxDaniel WynnStanley CohanDonna RillDawn McGuireClyde Markowitz. (2011) A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design. Multiple Sclerosis Journal 18:6, pages 843-852.
Crossref
Crossref
Ghislain Opdenakker & Jo Van Damme. (2011) Probing cytokines, chemokines and matrix metalloproteinases towards better immunotherapies of multiple sclerosis. Cytokine & Growth Factor Reviews 22:5-6, pages 359-365.
Crossref
Crossref
Loredana La Mantia, Alberto Vaona, Marco Rovaris, Francesco Berardo, Serena Frau, Anna Gandini, Anna Longobardi, Giulio Rigon, Carlo Di Pietrantonj & Bianca Weinstock-Guttman. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Ma?gorzata Siger, Agnieszka Durko, Agnieszka Nicpan, Maria Konarska, Monika Grudziecka & Krzysztof Selmaj. (2011) Discontinuation of interferon beta therapy in multiple sclerosis patients with high pre-treatment disease activity leads to prompt return to previous disease activity. Journal of the Neurological Sciences 303:1-2, pages 50-52.
Crossref
Crossref
Donald J. AbrahamDonna M. Huryn. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
547
568
.
Kerstin WolkKatrin WitteRobert Sabat. (2010) Interleukin-28 and Interleukin-29: Novel Regulators of Skin Biology. Journal of Interferon & Cytokine Research 30:8, pages 617-628.
Crossref
Crossref
Katrin Witte, Ellen Witte, Robert Sabat & Kerstin Wolk. (2010) IL-28A, IL-28B, and IL-29: Promising cytokines with type I interferon-like properties. Cytokine & Growth Factor Reviews 21:4, pages 237-251.
Crossref
Crossref
Laura Codarri, Adriano Fontana & Burkhard Becher. (2010) Cytokine networks in multiple sclerosis: lost in translation. Current Opinion in Neurology 23:3, pages 205-211.
Crossref
Crossref
Tobias D. Merson, Michele D. Binder & Trevor J. Kilpatrick. (2010) Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS. NeuroMolecular Medicine 12:2, pages 99-132.
Crossref
Crossref
Zhenshan XuWeidong DuPing ZhangXuan WangXueling MaLiqin ShiLihua Song. (2010) Development of a Protein Biochip to Identify 6 Monoclonal Antibodies Against Subtypes of Recombinant Human Interferons. ASSAY and Drug Development Technologies 8:2, pages 212-218.
Crossref
Crossref
K Witte, G Gruetz, H-D Volk, A C Looman, K Asadullah, W Sterry, R Sabat & K Wolk. (2009) Despite IFN-λ receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes & Immunity 10:8, pages 702-714.
Crossref
Crossref
Paolo Zamboni, Roberto Galeotti, Erica Menegatti, Anna Maria Malagoni, Sergio Gianesini, Ilaria Bartolomei, Francesco Mascoli & Fabrizio Salvi. (2009) A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. Journal of Vascular Surgery 50:6, pages 1348-1358.e3.
Crossref
Crossref
Thor Petersen, Anné Møller-Larsen, Steffen Thiel, Tomasz Brudek, Troels Krarup Hansen & Tove Christensen. (2009) Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis. Journal of Neuroimmunology 215:1-2, pages 108-116.
Crossref
Crossref
Jui-Hung Yen & Doina Ganea. (2009) Interferon β induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood 114:7, pages 1344-1354.
Crossref
Crossref
MDC Cénit, F Blanco-Kelly, V de las Heras, M Bartolomé, EG de la Concha, E Urcelay, R Arroyo & A Martínez. (2009) Glypican 5 is an interferon-beta response gene: a replication study. Multiple Sclerosis Journal 15:8, pages 913-917.
Crossref
Crossref
Philipp A. LangLuisa Cervantes-BarraganAdmar VerschoorAlexander A. Navarini, Mike Recher, Marc PellegriniLukas FlatzAndreas BergthalerKenya Honda, Burkhard LudewigPamela S. OhashiKarl S. Lang. (2009) Hematopoietic cell–derived interferon controls viral replication and virus-induced disease. Blood 113:5, pages 1045-1052.
Crossref
Crossref
Coral González-García, Francisco M. Martín-Saavedra, Alicia Ballester & Sara Ballester. (2009) The Th17 lineage: Answers to some immunological questions. Inmunología 28:1, pages 32-45.
Crossref
Crossref